BTMD
Price
$1.09Alerts
Change
+$0.01 (+0.93%)
Updated
Nov 11 closing price
Capitalization
30.4M
126 days until earnings call
Intraday BUY SELL Signals
USPH
Price
$100.17Alerts
Change
+$0.94 (+0.95%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
1.48B
106 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BTMD vs USPH

BTMD vs USPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BTMD vs. USPH commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTMD is a Hold and USPH is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BTMD with price predictions
Nov 10, 2026

BTMD's RSI Indicator ascends from oversold territory

The RSI Oscillator for BTMD moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 23 of the 28 cases the stock moved higher. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 68 cases where BTMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for BTMD just turned positive on October 08, 2026. Looking at past instances where BTMD's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.

Following a +6.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where BTMD advanced for three days, in 179 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BTMD as a result. In 73 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BTMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

BTMD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BTMD entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.462) is normal, around the industry mean (204.532). P/E Ratio (5.889) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.243) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. BTMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for USPH with price predictions
Nov 10, 2026

Momentum Indicator for USPH turns positive, indicating new upward trend

USPH saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 56 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for USPH just turned positive on November 05, 2026. Looking at past instances where USPH's MACD turned positive, the stock continued to rise in 27 of 42 cases over the following month. The odds of a continued upward trend are 64%.

Following a +2.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where USPH advanced for three days, in 219 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 167 of 254 cases where USPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

USPH broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. USPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.309) is normal, around the industry mean (204.532). USPH's P/E Ratio (585.235) is considerably higher than the industry average of (21.572). Projected Growth (PEG Ratio) (2.823) is also within normal values, averaging (2.498). Dividend Yield (0.018) settles around the average of (0.154) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (2.688).

FUNDAMENTALS RATINGS
USPH: Fundamental Ratings
USPH
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BTMDUSPH
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
Bearish Trend 22 days ago
82%
Bearish Trend 9 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
66%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BTMD: $1.08 vs. USPH: $99.24)
Brand notoriety: BTMD and USPH are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: BTMD: 15% vs. USPH: 94%
Market capitalization -- BTMD: $30.4M vs. USPH: $1.48B
BTMD [@Hospital/Nursing Management] is valued at $30.4M. USPH’s [@Hospital/Nursing Management] market capitalization is $1.48B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTMD’s FA Score shows that 1 FA rating(s) are green while USPH’s FA Score has 1 green FA rating(s).

  • BTMD’s FA Score: 1 green, 4 red.
  • USPH’s FA Score: 1 green, 4 red.
According to our system of comparison, USPH is a better buy in the long-term than BTMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTMD’s TA Score shows that 4 TA indicator(s) are bullish while USPH’s TA Score has 4 bullish TA indicator(s).

  • BTMD’s TA Score: 4 bullish, 4 bearish.
  • USPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BTMD and USPH are a good buy in the short-term.

Price Growth

BTMD (@Hospital/Nursing Management) experienced а -3.57% price change this week, while USPH (@Hospital/Nursing Management) price change was +17.11% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.65%. For the same industry, the average monthly price growth was +0.49%, and the average quarterly price growth was +11.07%.

Reported Earning Dates

BTMD is expected to report earnings on Mar 17, 2027.

USPH is expected to report earnings on Feb 25, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-5.65% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

USPH and

Correlation & Price change

A.I.dvisor tells us that USPH and BTMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USPH and BTMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USPH
1D Price
Change %
USPH100%
-0.60%
BTMD - USPH
30%
Poorly correlated
-2.70%
OPCH - USPH
29%
Poorly correlated
-0.13%
UHS - USPH
27%
Poorly correlated
-0.89%
THC - USPH
27%
Poorly correlated
+0.44%
ENSG - USPH
25%
Poorly correlated
+1.64%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
M25.080.13
+0.52%
Macy's
HCA504.42-0.47
-0.09%
HCA Healthcare
NKTR37.78-0.05
-0.12%
Nektar Therapeutics
KOSS3.25-0.05
-1.52%
Koss Corp
NMG0.81-0.06
-6.77%
Nouveau Monde Graphite